Log In Sign up
The largest database of trusted experimental protocols

Drg hepcidin 25 bioactive high sensitive elisa kit

Manufactured by DRG International
Visit Supplier

The DRG Hepcidin 25 (bioactive) High Sensitive ELISA kit is a quantitative in vitro diagnostic test used for the measurement of Hepcidin-25 levels in human serum and plasma samples. The kit utilizes the enzyme-linked immunosorbent assay (ELISA) principle to detect and quantify the target analyte.

Automatically generated - may contain errors

Lab products found in correlation

Chemiluminescent microparticle immunoassay, by Abbott (6 mentions) Multigent crp vario assay, by Abbott (6 mentions) Dna blood mini kit, by Qiagen (2 mentions)

Spelling variants of this product

ELISAs (7 citations) DRG ELISA Kit (5 citations) Hepcidin 25 (2 citations)

6 protocols using drg hepcidin 25 bioactive high sensitive elisa kit

1

Birth Cohort Study on Vaccination Response

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
EMaBS is a prospective birth cohort that was originally designed as an RCT to test whether anthelminthic treatment during pregnancy and early childhood was associated with differential response to vaccination or incidence of infections, such as pneumonia, diarrhea or malaria (http://emabs.lshtm.ac.uk/)45 (link). This cohort was part of the VaccGene study as described elsewhere46 . Blood samples were collected in Vacutainer tubes containing EDTA at birth and at subsequent birthdays up to 5 years of age. Anthropometry and biomarkers of iron and inflammation were measured in samples from a single annual visit based on the availability of stored samples. Serum ferritin (Chemiluminescent Microparticle Immunoassay, Abbott Architect), CRP (Multigent CRP Vario assay, Abbott Architect), hepcidin (DRG Hepcidin-25 (bioactive) High Sensitive ELISA kit (DRG International)), hemoglobin (Coulter analyzer, Beckman Coulter) and malaria parasitemia (Giemsa-stained thick and thin blood films) were measured. Genotyping of sickle cell trait in the VaccGene study is described below.
Muriuki J.M., Mentzer A.J., Mitchell R., Webb E.L., Etyang A.O., Kyobutungi C., Morovat A., Kimita W., Ndungu F.M., Macharia A.W., Ngetsa C.J., Makale J., Lule S.A., Musani S.K., Raffield L.M., Cutland C.L., Sirima S.B., Diarra A., Tiono A.B., Fried M., Gwamaka M., Seth A.A., Wirth J.P., Wegmüller R., Madhi S.A., Snow R.W., Hill A.V., Rockett K.A., Sandhu M.S., Kwiatkowski D.P., Prentice A.M., Byrd K.A., Ndjebayi A., Stewart C.P., Engle-Stone R., Green T.J., Karakochuk C.D., Suchdev P.S., Bejon P., Duffy P.E., Smith G.D., Elliott A.M., Williams T.N, & Atkinson S.H. (2021). Malaria is a cause of iron deficiency in African children. Nature medicine, 27(4), 653-658.
+ Open protocol
+ Expand
2

Longitudinal Malaria Immunity Evaluation

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
This was an ongoing rolling longitudinal study designed to evaluate immunity to malaria in children and is described elsewhere40 (link). Within this cohort, children were followed to 8 years of age with weekly follow-ups and annual cross-sectional surveys during which anthropometry measurements were made and blood samples were collected. Serum ferritin (Chemiluminescent Microparticle Immunoassay, Abbott Architect), hepcidin (DRG Hepcidin 25 (bioactive) High Sensitive ELISA kit (DRG International)), CRP (Multigent CRP Vario assay, Abbott Architect), hemoglobin (Coulter analyzer, Beckman Coulter) and malaria parasitemia (Giemsa-stained thick and thin blood films) were measured from blood samples collected at a single cross-sectional survey based on the availability of plasma samples archived at 80°C. Genotyping of hemoglobin types and α-thalassemia was conducted by PCR35 (link),36 (link) using DNA extracted with the Qiagen DNA Blood Mini kit (Qiagen).
Muriuki J.M., Mentzer A.J., Mitchell R., Webb E.L., Etyang A.O., Kyobutungi C., Morovat A., Kimita W., Ndungu F.M., Macharia A.W., Ngetsa C.J., Makale J., Lule S.A., Musani S.K., Raffield L.M., Cutland C.L., Sirima S.B., Diarra A., Tiono A.B., Fried M., Gwamaka M., Seth A.A., Wirth J.P., Wegmüller R., Madhi S.A., Snow R.W., Hill A.V., Rockett K.A., Sandhu M.S., Kwiatkowski D.P., Prentice A.M., Byrd K.A., Ndjebayi A., Stewart C.P., Engle-Stone R., Green T.J., Karakochuk C.D., Suchdev P.S., Bejon P., Duffy P.E., Smith G.D., Elliott A.M., Williams T.N, & Atkinson S.H. (2021). Malaria is a cause of iron deficiency in African children. Nature medicine, 27(4), 653-658.
+ Open protocol
+ Expand
3

Birth Cohort Study on Vaccination Response

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
EMaBS is a prospective birth cohort that was originally designed as an RCT to test whether anthelminthic treatment during pregnancy and early childhood was associated with differential response to vaccination or incidence of infections, such as pneumonia, diarrhea or malaria (http://emabs.lshtm.ac.uk/)45 (link). This cohort was part of the VaccGene study as described elsewhere46 . Blood samples were collected in Vacutainer tubes containing EDTA at birth and at subsequent birthdays up to 5 years of age. Anthropometry and biomarkers of iron and inflammation were measured in samples from a single annual visit based on the availability of stored samples. Serum ferritin (Chemiluminescent Microparticle Immunoassay, Abbott Architect), CRP (Multigent CRP Vario assay, Abbott Architect), hepcidin (DRG Hepcidin-25 (bioactive) High Sensitive ELISA kit (DRG International)), hemoglobin (Coulter analyzer, Beckman Coulter) and malaria parasitemia (Giemsa-stained thick and thin blood films) were measured. Genotyping of sickle cell trait in the VaccGene study is described below.
Muriuki J.M., Mentzer A.J., Mitchell R., Webb E.L., Etyang A.O., Kyobutungi C., Morovat A., Kimita W., Ndungu F.M., Macharia A.W., Ngetsa C.J., Makale J., Lule S.A., Musani S.K., Raffield L.M., Cutland C.L., Sirima S.B., Diarra A., Tiono A.B., Fried M., Gwamaka M., Seth A.A., Wirth J.P., Wegmüller R., Madhi S.A., Snow R.W., Hill A.V., Rockett K.A., Sandhu M.S., Kwiatkowski D.P., Prentice A.M., Byrd K.A., Ndjebayi A., Stewart C.P., Engle-Stone R., Green T.J., Karakochuk C.D., Suchdev P.S., Bejon P., Duffy P.E., Smith G.D., Elliott A.M., Williams T.N, & Atkinson S.H. (2021). Malaria is a cause of iron deficiency in African children. Nature medicine, 27(4), 653-658.
+ Open protocol
+ Expand
4

Malaria vaccine trial in Burkina Faso

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
This was part of the VaccGene study, which aimed to identify genetic variants associated with differential response to vaccination in infancy but with ethical approval to undertake analyses to examine the effect of iron status on infection susceptibility. Details of the study design are described elsewhere37 (link). Infants between the ages of 6 and 18 months living in the Banfora region of Burkina Faso were recruited into a phase 1–2b clinical trial to test the safety, immunogenicity and efficacy of an experimental heterologous viral-vectored prime-boost liver-stage malaria vaccine37 (link). Serum ferritin (Chemiluminescent Microparticle Immunoassay, Abbott Architect), hepcidin (DRG Hepcidin 25 (bioactive) High Sensitive ELISA kit (DRG International)), CRP (Multigent CRP Vario assay, Abbott Architect), hemoglobin (Coulter analyzer, Beckman Coulter) and malaria parasitemia (Giemsa-stained thick and thin blood films) were measured at a single time point. Genotyping of sickle cell trait in the VaccGene study is described below.
Muriuki J.M., Mentzer A.J., Mitchell R., Webb E.L., Etyang A.O., Kyobutungi C., Morovat A., Kimita W., Ndungu F.M., Macharia A.W., Ngetsa C.J., Makale J., Lule S.A., Musani S.K., Raffield L.M., Cutland C.L., Sirima S.B., Diarra A., Tiono A.B., Fried M., Gwamaka M., Seth A.A., Wirth J.P., Wegmüller R., Madhi S.A., Snow R.W., Hill A.V., Rockett K.A., Sandhu M.S., Kwiatkowski D.P., Prentice A.M., Byrd K.A., Ndjebayi A., Stewart C.P., Engle-Stone R., Green T.J., Karakochuk C.D., Suchdev P.S., Bejon P., Duffy P.E., Smith G.D., Elliott A.M., Williams T.N, & Atkinson S.H. (2021). Malaria is a cause of iron deficiency in African children. Nature medicine, 27(4), 653-658.
+ Open protocol
+ Expand
5

Malaria vaccine trial in Burkina Faso

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
This was part of the VaccGene study, which aimed to identify genetic variants associated with differential response to vaccination in infancy but with ethical approval to undertake analyses to examine the effect of iron status on infection susceptibility. Details of the study design are described elsewhere37 (link). Infants between the ages of 6 and 18 months living in the Banfora region of Burkina Faso were recruited into a phase 1–2b clinical trial to test the safety, immunogenicity and efficacy of an experimental heterologous viral-vectored prime-boost liver-stage malaria vaccine37 (link). Serum ferritin (Chemiluminescent Microparticle Immunoassay, Abbott Architect), hepcidin (DRG Hepcidin 25 (bioactive) High Sensitive ELISA kit (DRG International)), CRP (Multigent CRP Vario assay, Abbott Architect), hemoglobin (Coulter analyzer, Beckman Coulter) and malaria parasitemia (Giemsa-stained thick and thin blood films) were measured at a single time point. Genotyping of sickle cell trait in the VaccGene study is described below.
Muriuki J.M., Mentzer A.J., Mitchell R., Webb E.L., Etyang A.O., Kyobutungi C., Morovat A., Kimita W., Ndungu F.M., Macharia A.W., Ngetsa C.J., Makale J., Lule S.A., Musani S.K., Raffield L.M., Cutland C.L., Sirima S.B., Diarra A., Tiono A.B., Fried M., Gwamaka M., Seth A.A., Wirth J.P., Wegmüller R., Madhi S.A., Snow R.W., Hill A.V., Rockett K.A., Sandhu M.S., Kwiatkowski D.P., Prentice A.M., Byrd K.A., Ndjebayi A., Stewart C.P., Engle-Stone R., Green T.J., Karakochuk C.D., Suchdev P.S., Bejon P., Duffy P.E., Smith G.D., Elliott A.M., Williams T.N, & Atkinson S.H. (2021). Malaria is a cause of iron deficiency in African children. Nature medicine, 27(4), 653-658.
+ Open protocol
+ Expand
6

Longitudinal Malaria Immunity Evaluation

Cited 1 time
Check if the same lab product or an alternative is used in the 5 most similar protocols
This was an ongoing rolling longitudinal study designed to evaluate immunity to malaria in children and is described elsewhere40 (link). Within this cohort, children were followed to 8 years of age with weekly follow-ups and annual cross-sectional surveys during which anthropometry measurements were made and blood samples were collected. Serum ferritin (Chemiluminescent Microparticle Immunoassay, Abbott Architect), hepcidin (DRG Hepcidin 25 (bioactive) High Sensitive ELISA kit (DRG International)), CRP (Multigent CRP Vario assay, Abbott Architect), hemoglobin (Coulter analyzer, Beckman Coulter) and malaria parasitemia (Giemsa-stained thick and thin blood films) were measured from blood samples collected at a single cross-sectional survey based on the availability of plasma samples archived at 80°C. Genotyping of hemoglobin types and α-thalassemia was conducted by PCR35 (link),36 (link) using DNA extracted with the Qiagen DNA Blood Mini kit (Qiagen).
Muriuki J.M., Mentzer A.J., Mitchell R., Webb E.L., Etyang A.O., Kyobutungi C., Morovat A., Kimita W., Ndungu F.M., Macharia A.W., Ngetsa C.J., Makale J., Lule S.A., Musani S.K., Raffield L.M., Cutland C.L., Sirima S.B., Diarra A., Tiono A.B., Fried M., Gwamaka M., Seth A.A., Wirth J.P., Wegmüller R., Madhi S.A., Snow R.W., Hill A.V., Rockett K.A., Sandhu M.S., Kwiatkowski D.P., Prentice A.M., Byrd K.A., Ndjebayi A., Stewart C.P., Engle-Stone R., Green T.J., Karakochuk C.D., Suchdev P.S., Bejon P., Duffy P.E., Smith G.D., Elliott A.M., Williams T.N, & Atkinson S.H. (2021). Malaria is a cause of iron deficiency in African children. Nature medicine, 27(4), 653-658.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!